Ironwood Pharmaceuticals Inc. Class A (IRWD)

Business: Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products.

IPO Date: 03-Feb-2010

Exec. Chairman: Ms. Julie H. McHugh

CEO & Director: Mr. Thomas A. McCourt

Listing: NASDAQ: IRWD

Country: United States

Headquarters: Boston, MA

Website: https://www.ironwoodpharma.com

Market cap: $1,784.52 Mln

Revenue (TTM): $422.44 Mln

Earnings (TTM): $527.32 Mln

Cash: $593.37 Mln

Total Debt: $536.76 Mln

Insider's Holding: 1.82%

Liquidity: Low

52 Week range: $10.13 - 14.27

Shares outstanding: 153,838,000

10 Years Aggregate:

• CFO: $-359.91 Mln
• EBITDA: $-429.70 Mln
• Net Profit: $-502.61 Mln